Skip to content

Effectiveness of exercise (30 min walk) on Myasthenia Gravis patients.

A study to assess the effectiveness of exercise (30 min walk) on Health-Related Quality of Life (HRQoL) among Myasthenia Gravis patients attending Neuro OPD at AIIMS, New Delhi - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069597
Enrollment
40
Registered
2024-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G700- Myasthenia gravis

Interventions

Intervention1: 30 MIN WALKING: Pre Test will be done by checking the baseline MGQoL-15 and MGADL score. Patients will be asked to walk for 10 min in a straight corridor infront of the researcher in

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Myasthenia Gravis patients attending Neurology OPD at AIIMS, New Delhi. 2 MG patients who are willing to participate in the study. 3 MG patients who are able to follow commands and instructions. 4 MG patients with MG (MGFA class 2 and 3 ) and able to undergo 6 min walk test(6MWT). 5 MG patients who have the access of smart phone or smart watches.

Exclusion criteria

Exclusion criteria: 1 MG patients who are walking for more than 150 min per week. 2 Any contraindication to exercise. 3 MG patient with other co-morbid conditions. 4 Physically disabled MG patients. 5 MG patients who are not able to communicate in Hindi or English.

Design outcomes

Primary

MeasureTime frame
To access the effectiveness of exercise(30 min walk) on health-related quality of life (HRQoL) of MG patients.Timepoint: before and after 4 weeks of intervention or standard care provided to the patients

Secondary

MeasureTime frame
To find out the effect of exercise (30 min walk) on activities of daily living of MG patient. To find out the association between MG-QoL & selected demographic variables Timepoint: after 4 weeks of intervention or standard care provided to the patients

Countries

India

Contacts

Public ContactNeha Sah

All India Institute of Medical Sciences, New Delhi

sibiriju@gmail.com9958879808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026